SLB
56
-3
VLO
42
2
DUK
50
-2
NRG
50
-2
HUM
48
2
VNO
60
8
MAT
38
-3
MS
80
-3
PDCO
30
-6
CAH
60
2
DLTR
40
4
GOOGL
59
-8
HES
66
3
AON
60
2
MMM
42
5
DIS
62
2
KEY
46
-2
ROK
67
5
STI
31
19
HRL
30
-3
SLB
56
-3
VLO
42
2
DUK
50
-2
NRG
50
-2
HUM
48
2
VNO
60
8
MAT
38
-3
MS
80
-3
PDCO
30
-6
CAH
60
2
DLTR
40
4
GOOGL
59
-8
HES
66
3
AON
60
2
MMM
42
5
DIS
62
2
KEY
46
-2
ROK
67
5
STI
31
19
HRL
30
-3
Financhill
Back

Aligos Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
69

ALGS
Aligos Therapeutics

Last Price:
19.46
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Aligos Therapeutics Price Quote

$19.46
+0.01 (+0.05%)
(Updated: November 14, 2024 at 5:55 PM ET)

Aligos Therapeutics Key Stats

Buy
69
Aligos Therapeutics (ALGS) is a Buy
Day range:
$18.20 - $21.89
52-week range:
$6.76 - $30.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.67
P/B ratio:
1.39%
Volume:
1.2M
Avg. volume:
298.2K
1-year change:
29.67%
Market cap:
$69.8M
Revenue:
$15.5M
EPS:
$-17.11

How Much Does Aligos Therapeutics Make?

Is Aligos Therapeutics Growing As A Company?

  • What Is Aligos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.61%
  • What Is Aligos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Aligos Therapeutics Stock Price Performance

What Is Aligos Therapeutics 52-Week High & Low?

Aligos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aligos Therapeutics?

Is Aligos Therapeutics Cash Flow Positive?

  • What Is ALGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$85M
  • What Is Aligos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $88.2M
  • What Is Aligos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$38.3M

Aligos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ALGS return on invested capital is -118.75%
  • What Is Aligos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -68.4%
  • What Is ALGS Return On Equity?
    ROE is a measure of profitability and is -118.75%

Aligos Therapeutics Earnings Date & Stock Price

Aligos Therapeutics Competitors

Aligos Therapeutics Dividend Yield

Aligos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -131.7%
Revenue: -60.82% 280.7%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 103.33
Upside from Last Price: 431.28%

Major Shareholders

  • How many ALGS shares are owned by institutional investors?
    57.5M ALGS shares are owned by institutional investors
  • How many ALGS shares are owned by insiders?
    0 ALGS shares are owned by insiders